RZH
NVO

Relyea Zuckerberg Hanson’s Novo Nordisk NVO Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,126
Closed -$372K – 266
2024
Q3 		$372K Sell
3,126
-32
-1% -$4.27K 0.06% 173
2024
Q2 		$451K Buy
3,158
+16
+0.5% +$2.12K 0.08% 134
2024
Q1 		$403K Sell
3,142
-17
-0.5% -$2.02K 0.07% 141
2023
Q4 		$327K Buy
3,159
+99
+3% +$9.79K 0.06% 157
2023
Q3 		$278K Buy
+3,060
New +$270K 0.06% 152

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Relyea Zuckerberg Hanson's NVO Position: Q4 2024 in Review

Relyea Zuckerberg Hanson sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,126 shares — an estimated $372K sold.

Relyea Zuckerberg Hanson first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $451K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Relyea Zuckerberg Hanson reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Relyea Zuckerberg Hanson sold 3,126 Novo Nordisk shares in Q4 2024, an estimated $372K.
  • Relyea Zuckerberg Hanson first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • Relyea Zuckerberg Hanson's Novo Nordisk position peaked at $451K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Relyea Zuckerberg Hanson's 13F filing for Q4 2024, filed 15 Jan 2025.